Fortrea Holdings Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
45.8%projected annual EPS growth
Analyst Coverage
11analysts covering
FY EPS (est.)
$0.84next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Earnings Release | 9 Nov 2026 |
Monitoring Framework
Key Performance Indicators
Book-to-Bill Ratio Quarterly115.0%Target: >1.10x
Backlog Quarterly7.8BTarget: Sustained growth
Adjusted EBITDA Quarterly47MTarget: 190,000,000 to 220,000,000 (FY 2026)
Watch Items
- Biotech Funding Environment and Client Decision-Making CyclesTrigger: Elongated sales cycles or budget constraints leading to book-to-bill dropping below 1.0xAction: Re-evaluate revenue growth assumptions and adjust cost structure to protect margins
- Post-Spinoff Cost Optimization and TSA ExitsTrigger: Failure to achieve targeted cost savings or unexpected transition service agreement expensesAction: Review SG&A run-rate and accelerate operational restructuring initiatives
Research as of 20 Jun 2026